期刊文献+

氯化铝染毒大鼠海马组织NMDAR-ERK通路调节H3K9ac、H3K9me2、HP1和BDNF蛋白的表达 被引量:3

Expression of H3K9ac,H3K9me2,HP1,and BDNF Mediated by NMDAR-ERK Pathway in Hippocampus Tissues of Rats Exposed to Aluminum Chloride
原文传递
导出
摘要 [目的]研究慢性染铝对大鼠海马组织N-甲基-D-天冬氨酸受体(NMDAR)、p-细胞外信号调节蛋白激酶(p-ERK)、H3K9ac、H3K9me2、HP1、BDNF表达量的影响。[方法]雄性SD大鼠,SPF级,共24只,按体重随机分为对照组(自来水)和铝染毒2、12、72 mg/kg组,每组6只。染毒组每天经饮水染毒Al Cl3,共持续120 d。染毒结束后,用Western blot法测定各种蛋白表达量。[结果]与对照组相比,72 mg/kg组海马中NMDAR、p-ERK的表达量均降低(P<0.05);72 mg/kg组H3K9ac、BDNF的表达量与对照组比较均下降(均P<0.01),且随着染毒剂量的增加表达量均呈下降趋势(rNMDAR=-0.61;rp-ERK=-0.69;rH3K9ac=-0.93;rBDNF=-0.73,均P<0.05);而72 mg/kg组H3K9me2、HP1的蛋白表达量均高于对照组(P<0.05,P<0.01),且随着染毒剂量的增加表达量呈上升趋势(rH3K9me2=0.67;rHP1=0.72,均P<0.01)。[结论]铝可能经NMDAR-ERK通路引起大鼠海马组织H3K9ac、H3K9me2、HP1、BDNF表达量发生改变。 [ Objective ]To examine expression levels of N-methyl-D-aspartate receptor (NMDAR), phosphorylated- extracellular signal regulated protein kinase (p-ERK), H3K9ac, H3K9me2, HP1, and BDNF in hippocampus tissue of rats chronically exposed to aluminum. [ Methods ] Twenty-four male SD rats (specific pathogen free) were randomly selected by body weight into four groups, in which drinking water contained 0, 2, 12, and 72mg/kg of aluminum chloride (AlCl_3) for 120d respectively. The protein expression levels of NMDAR, pERK, H3K9ac, H3K9me2, HP1, and BDNF were detected by Western blot. [ Results ] Compared with the control group, the expression levels of NMDAR, pERK, H3K9ac, and BDNF in hippocampus of the 72 mg/kg aluminum exposed group were significantly lower (P 〈 0.05 or P〈 0.01) in an inverse dose-dependent manner (r_NMVAR=-0.61, r_pEsr=-0.69, r_H3K9se=--0.93, and r_SDNF=--0.73, all PS 〈 0.05). However, the expression levels of H3K9me2 and HP1 in hippocampus of the 72 mg/kg aluminum exposed group were both significantly higher (P 〈 0.05) in a dose-dependent manner (r_H3Kg2=0.67 and r_Hp1=0.72, both Ps〈0.01). [ Conclusion ] Chronic aluminum exposure may change the expression of H3K9ac, H3K9me2, HP1, and BDNF via NMDAR-ERK pathway.
出处 《环境与职业医学》 CAS CSCD 北大核心 2016年第7期657-660,共4页 Journal of Environmental and Occupational Medicine
基金 国家自然科学基金项目(编号:81372968)
关键词 N-甲基-D-天冬氨酸受体 细胞外信号调节蛋白激酶 组蛋白乙酰化 组蛋白甲基化 异染色质蛋白-1 脑源性神经营养因子 aluminum N-methyI-D-aspartate receptor extracellular signal regulated protein kinase histone acetylation histone methylation heterochromatin protein 1 brain derived neurotrophic factor
  • 相关文献

参考文献15

  • 1Yuan CY, Hsu GS, Lee YJ. Aluminum alters NMDA receptor 1A and 2A/B expression on neonatal hippocampal neurons in rats[J]. J Siomed Sci, 2011, 18( 1 ): 81-89.
  • 2Krapivinsky G, Krapivinsky L, Manasian Y, et al. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1 [J]. Neuron, 2003, 40( 4 ): 775-784.
  • 3Chwang W B, Arthur J S, Schumacher A, et al. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation[J]. J Neurosci, 2007, 27(46): 12732-12742.
  • 4Rice J C, Allis C D. Histone methylation versus histone acetylation: new insights into epigenetic regulation [J]. Cell Biol, 2001, 13( 3 ): 263-273.
  • 5Gupta S, Kim S Y, Artis S, et al. Histone methylation regulates memory formation[J]. J Neurosci, 2010, 30( 10 ): 3589-3599.
  • 6黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1317
  • 7Levenson JM, O'Riordan K J, Brown KD, et al. Regulation of histone acetylation during memory formation in the hippocampus [J]. J Biol Chem, 2004, 279( 39 ): 40545-40559.
  • 8Stewart M D, Li J, Wong J. Relationship between histone H3 lysin9 methylation, transcription repression, and heterochromatin proteinl recruiment [J]. Mol Cell Biol, 2005, 25(7 ): 2525-2538.
  • 9Black J C, Van Rechem C, Whetstine J R. Histone lysine methylation dynamics: establishment, regulation and biological impact[J]. Mol Cell, 2012, 48( 4 ): 491-507.
  • 10Hiragami K, Festenstein R. Heteroehromatin protein 1: a pervasive controlling influence [J]. Cell Mol Life Sci, 2005, 62(23 ): 2711-2726.

二级参考文献3

  • 1[4]ww.fda.gov/cder/cancer/animalframe.htm
  • 2[5]FDA Guidance for industry and reviewers: Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers[ S]. 2002; 12
  • 3[6]FDA Guidance for Industry: food-effect bioavailability and fed bioequivalence studies[ S]. 2002; 12

共引文献1316

同被引文献34

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部